Hospital Municipal de Badalona-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2024

  1. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia

    International Journal of Antimicrobial Agents, Vol. 64, Núm. 2

2011

  1. Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: The AVACROSS study

    Oncologist, Vol. 16, Núm. 5, pp. 614-620

2010

  1. Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer

    Chemotherapy, Vol. 56, Núm. 2, pp. 142-146